.After taking a look at stage 1 record, Nuvation Bio has actually chosen to halt work on its single ...
.Zevra Rehabs' rare disease medication seems to become on the pathway to permission this autumn afte...
.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics therapy failure has gone a $230 million...
.After more than 20 years of work with neurodegenerative diseases, Swiss biotech a/c Immune cases it...
.GSK has broken up a phase 2 individual papillomavirus (HPV) injection coming from its pipe after de...
.Operating system Therapies are going to detail on the NYSE American supply substitution today using...
.ALX Oncology's period 2 gastric cancer reaction fee has actually deteriorated. After finding its CD...
.Another of Ionis Pharmaceuticals' key midphase readouts has fallen short of expectations, urging th...
.While Biogen's pharma peers are looking for late-stage resources with little risk, chief executive ...
.Instil Bio has actually been actually a biotech trying to find a pipeline after it scrapped its own...